0001209191-22-020285.txt : 20220321
0001209191-22-020285.hdr.sgml : 20220321
20220321171804
ACCESSION NUMBER: 0001209191-22-020285
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220321
FILED AS OF DATE: 20220321
DATE AS OF CHANGE: 20220321
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaye Randall
CENTRAL INDEX KEY: 0001350416
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40192
FILM NUMBER: 22756396
MAIL ADDRESS:
STREET 1: 11388 SORRENTO VALLEY ROAD
STREET 2: STE. 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Longboard Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001832168
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 845009619
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE
STREET 2: SUITE 950
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 619-592-9775
MAIL ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE
STREET 2: SUITE 950
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-21
0
0001832168
Longboard Pharmaceuticals, Inc.
LBPH
0001350416
Kaye Randall
4275 EXECUTIVE SQUARE
SUITE 950
LA JOLLA
CA
92037
0
1
0
0
CMO
Stock Option (Right to Buy)
6.00
2022-03-21
4
A
0
206500
0.00
A
2032-03-20
Voting common stock
206500
206500
D
1/4th of the shares subject to the stock option vest on March 21, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.
/s/ Brandi L. Roberts, Attorney-In-Fact
2022-03-21